Mitochondrial Medicine 2018 conference
OVERVIEW
Mitochondrial Medicine 2018 conference is organized by United Mitochondrial Disease Foundation (UMDF) and will be held during Jun 27 - 30, 2018 at Sheraton Music City Hotel, Nashville, Tennessee, United States of America.
The target audience for this medical event is Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, and Residents/Fellows/Students. This CME Conference has been approved for a maximum of 19.75 AMA PRA Category I Credits.
Course Description:
The UMDF mission is to promote research and education for the diagnosis, treatment and cure of mitochondrial disorders and to provide support to affected individuals and families.
Course Objectives:
• Learn about newly characterized mitochondrial enzymes.
• Become familiar with new insights into mitochondrial redox biochemistry and how this may be applied to developing new therapies for mitochondrial diseases.
• Learn how mitochondrial dysfunction affects the metabolic profile.
• Discover how imagining mass spectrometry can be used to understand mitochondrial function.
• Summarize how drugs can be developed that target them to the mitochondria.
• Describe the efforts of drug repurposing and how old medications may result in mitochondrial therapeutics.
• List the new developments in clinical trials in mitochondrial disease and distinguish the differences in their mechanisms of action.
• Demonstrate how the mitochondria can serve as an undesired target of pharmaceuticals and environmental exposures.
Scientific/Clinical Program: June 27-30, 2018
Patient/Family and LHON Program: June 28-30, 2018
Additional details will be posted as soon as they are available.
The target audience for this medical event is Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, and Residents/Fellows/Students. This CME Conference has been approved for a maximum of 19.75 AMA PRA Category I Credits.
Course Description:
The UMDF mission is to promote research and education for the diagnosis, treatment and cure of mitochondrial disorders and to provide support to affected individuals and families.
Course Objectives:
• Learn about newly characterized mitochondrial enzymes.
• Become familiar with new insights into mitochondrial redox biochemistry and how this may be applied to developing new therapies for mitochondrial diseases.
• Learn how mitochondrial dysfunction affects the metabolic profile.
• Discover how imagining mass spectrometry can be used to understand mitochondrial function.
• Summarize how drugs can be developed that target them to the mitochondria.
• Describe the efforts of drug repurposing and how old medications may result in mitochondrial therapeutics.
• List the new developments in clinical trials in mitochondrial disease and distinguish the differences in their mechanisms of action.
• Demonstrate how the mitochondria can serve as an undesired target of pharmaceuticals and environmental exposures.
Scientific/Clinical Program: June 27-30, 2018
Patient/Family and LHON Program: June 28-30, 2018
Additional details will be posted as soon as they are available.
KEY DATES
27 Jun, 2018
Event Start Date
30 Jun, 2018
Event End Date
SPECIALITIES
GeneticsSUGGESTED HOTELS
CONFERENCE VENUE
Sheraton Music City HotelQuick Links